{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T13:03:20Z","timestamp":1776949400892,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["BIOCEV-FAR LQ1604"],"award-info":[{"award-number":["BIOCEV-FAR LQ1604"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["CZ.1.05\/1.1.00\/02.0109"],"award-info":[{"award-number":["CZ.1.05\/1.1.00\/02.0109"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["16-04863S"],"award-info":[{"award-number":["16-04863S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["907019"],"award-info":[{"award-number":["907019"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.msec.2019.109799","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T11:17:17Z","timestamp":1558955837000},"page":"109799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Hydrogel implants for transscleral drug delivery for retinoblastoma treatment"],"prefix":"10.1016","volume":"103","author":[{"given":"Ana-Irina","family":"Cocarta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radka","family":"Hobzova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Sirc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tereza","family":"Cerna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Hrabeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Svojgr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Pochop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Kodetova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarmila","family":"Jedelska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Bakowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Uhlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msec.2019.109799_bb0005","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/nrdp.2015.21","article-title":"Retinoblastoma","volume":"1","author":"Dimaras","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.msec.2019.109799_bb0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(13)70045-7","article-title":"Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies","volume":"14","author":"Rushlow","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.msec.2019.109799_bb0015","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.msec.2016.08.003","article-title":"Orbital implants: state-of-the-art review with emphasis on biomaterials and recent advances","volume":"69","author":"Baino","year":"2016","journal-title":"Mater. Sci. Eng. C."},{"key":"10.1016\/j.msec.2019.109799_bb0020","first-page":"2071","article-title":"Salvage chemosurgery for resistant or recurrent retinoblastoma","volume":"51","author":"Hung","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.msec.2019.109799_bb0025","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jamaophthalmol.2015.2243","article-title":"Enucleation vs ophthalmic artery chemosurgery for advanced intraocular retinoblastoma","volume":"133","author":"Yannuzzi","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.msec.2019.109799_bb0030","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/bip.10479","article-title":"Interaction of clinically important human DNA topoisomerase I poison, topotecan, with double-stranded DNA","volume":"72","author":"Streltsov","year":"2003","journal-title":"Biopolymers"},{"key":"10.1016\/j.msec.2019.109799_bb0035","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1016\/S0021-9258(17)38654-4","article-title":"Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase-I","volume":"260","author":"Hsiang","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.msec.2019.109799_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0378-4347(92)80420-U","article-title":"Determination of vinca alkaloids in mouse tissues by high-performance liquid chromatography","volume":"578","author":"Van Belle","year":"1992","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.msec.2019.109799_bb0045","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.jchromb.2011.05.031","article-title":"An HPLC method for the pharmacokinetic study of vincristine sulfate-loaded PLGA\u2013PEG nanoparticle formulations after injection to rats","volume":"879","author":"Chen","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.msec.2019.109799_bb0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3171\/2012.5.PEDS1277","article-title":"Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma","volume":"10","author":"Jabbour","year":"2012","journal-title":"J. Neurosurg. Pediatr."},{"key":"10.1016\/j.msec.2019.109799_bb0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.yaoo.2017.03.005","article-title":"Advances in Management of Retinoblastoma","volume":"2","author":"Syed","year":"2017","journal-title":"Adv. Ophthalmol. Optom."},{"key":"10.1016\/j.msec.2019.109799_bb0060","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications","volume":"96","author":"Munier","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.msec.2019.109799_bb0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/bjophthalmol-2012-301528","article-title":"Retinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavity","volume":"96","author":"Seregard","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.msec.2019.109799_bb0070","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/bjophthalmol-2013-303188","article-title":"Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review","volume":"97","author":"Smith","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.msec.2019.109799_bb0075","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/bjophthalmol-2011-301016","article-title":"Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track","volume":"96","author":"Munier","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.msec.2019.109799_bb0080","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Ghasemi Falavarjani","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.msec.2019.109799_bb0085","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bjophthalmol-2013-303885","article-title":"Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review","volume":"98","author":"Smith","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.msec.2019.109799_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-016-0204-6","article-title":"Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report","volume":"16","author":"Chao","year":"2016","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.msec.2019.109799_bb0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000448718","article-title":"Acute hemorrhagic retinopathy following intravitreal melphalan injection for retinoblastoma: a report of two cases and technical modifications to enhance the prevention of retinal toxicity","volume":"3","author":"Aziz","year":"2017","journal-title":"Ocul. Oncol. Pathol."},{"key":"10.1016\/j.msec.2019.109799_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2009.08.006","article-title":"Development of a highly stable and targetable nanoliposomal formulation of topotecan","volume":"141","author":"Drummond","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2019.109799_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejpb.2011.02.012","article-title":"Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release","volume":"79","author":"Souza","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.msec.2019.109799_bb0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jconrel.2006.03.002","article-title":"Pharmacokinetic and pharmacodynamic evaluation of a novel in situ forming poly(ethylene glycol)-based hydrogel for the controlled delivery of the camptothecins","volume":"112","author":"Lalloo","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2019.109799_bb0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2011.07.008","article-title":"Enhancement of the fraction of the active form of an antitumor drug topotecan via an injectable hydrogel","volume":"156","author":"Chang","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2019.109799_bb0120","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.colsurfb.2016.07.001","article-title":"Sustained-release hydrogels of topotecan for retinoblastoma","volume":"146","author":"Taich","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.msec.2019.109799_bb0125","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1167\/iovs.06-0030","article-title":"Delivery from episcleral exoplants","volume":"47","author":"Pontes de Carvalho","year":"2006","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.msec.2019.109799_bb0130","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1167\/iovs.09-4050","article-title":"Episcleral implants for topotecan delivery to the posterior segment of the eye","volume":"51","author":"Carcaboso","year":"2010","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.msec.2019.109799_bb0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00003088-199631020-00001","article-title":"Clinical pharmacokinetics of topotecan","volume":"31","author":"Herben","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.msec.2019.109799_bb0140","doi-asserted-by":"crossref","first-page":"8182","DOI":"10.1021\/jp303826c","article-title":"Structural photodynamic behavior of topotecan, a potent anticancer drug, in aqueous solutions at different pHs","volume":"116","author":"Di Nunzio","year":"2012","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.msec.2019.109799_bb0145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.22159\/ijpps.2017v9i4.16577","article-title":"Validated spectrophotometric method for the estimation of vincristine and vinblastine","volume":"9","author":"Jeewantha","year":"2017","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.msec.2019.109799_bb0150","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s13233-014-2134-6","article-title":"Synthesis of thermo-sensitive polyelectrolyte complex nanoparticles from CS-g-PNIPAM and SA-g-PNIPAM for controlled drug release","volume":"22","author":"Qi","year":"2014","journal-title":"Macromol. Res."},{"key":"10.1016\/j.msec.2019.109799_bb0155","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejpb.2018.12.013","article-title":"Lipodendriplexes: a promising nanocarrier for enhanced gene delivery with minimal cytotoxicity","volume":"135","author":"Tariq","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.msec.2019.109799_bb0160","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.1995.13.7.1786","article-title":"High-dose intravenous melphalan: a review","volume":"13","author":"Samuels","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.msec.2019.109799_bb0165","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1002\/cncr.27563","article-title":"Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity","volume":"118","author":"Qaddoumi","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.msec.2019.109799_bb0170","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.saa.2011.10.017","article-title":"Binding interactions of water-soluble camptothecin derivatives with bovine serum albumin","volume":"86","author":"Li","year":"2012","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.msec.2019.109799_bb0175","first-page":"259","article-title":"Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability","volume":"15","author":"Nicoli","year":"2009","journal-title":"Mol. Vis."},{"key":"10.1016\/j.msec.2019.109799_bb0180","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1755-3768.2012.02557.x","article-title":"Diffusion of macromolecules through sclera","volume":"91","author":"Miao","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.msec.2019.109799_bb0185","series-title":"Biomater. Dev. Adn Appl","first-page":"177","article-title":"Hydrogels in biology and medicine","author":"Michalek","year":"2010"},{"key":"10.1016\/j.msec.2019.109799_bb0190","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1016\/j.biomaterials.2004.01.058","article-title":"Drug release characteristics of phase separation pHEMA sponge materials","volume":"25","author":"Lou","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.msec.2019.109799_bb0195","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0928-4931(02)00290-4","article-title":"New polyelectrolyte hydrogels for biomedical applications","volume":"23","author":"Rosso","year":"2003","journal-title":"Mater. Sci. Eng. C."},{"key":"10.1016\/j.msec.2019.109799_bb0200","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0142-9612(00)00336-7","article-title":"Poly(2-hydroxyethyl methacrylate) film as a drug delivery system for pilocarpine","volume":"22","author":"Hsiue","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.msec.2019.109799_bb0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/185117a0","article-title":"Hydrophilic gels for biological use","volume":"185","author":"Wichterle","year":"1960","journal-title":"Nature"},{"key":"10.1016\/j.msec.2019.109799_bb0210","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijbiomac.2017.09.023","article-title":"Silk fibres grafted with 2-hydroxyethyl methacrylate (HEMA) and 4-hydroxybutyl acrylate (HBA) for biomedical applications","volume":"107","author":"Taddei","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.msec.2019.109799_bb0215","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.triboint.2011.06.035","article-title":"Mechanical and tribological properties of poly(hydroxyethyl methacrylate) hydrogels as articular cartilage substitutes","volume":"46","author":"Bostan","year":"2012","journal-title":"Tribol. Int."},{"key":"10.1016\/j.msec.2019.109799_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/5217095","article-title":"Embedding of bacterial cellulose nanofibers within PHEMA hydrogel matrices: tunable stiffness composites with potential for biomedical applications","volume":"2018","author":"Hobzova","year":"2018","journal-title":"J. Nanomater."},{"key":"10.1016\/j.msec.2019.109799_bb0225","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/pi.4199","article-title":"Methacrylate hydrogels reinforced with bacterial cellulose","volume":"61","author":"Hobzova","year":"2012","journal-title":"Polym. Int."},{"key":"10.1016\/j.msec.2019.109799_bb0230","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/pi.3194","article-title":"Rheological properties of homogeneous and heterogeneous poly(2-hydroxyethyl methacrylate) hydrogels","volume":"61","author":"Karpushkin","year":"2012","journal-title":"Polym. Int."},{"key":"10.1016\/j.msec.2019.109799_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151343","article-title":"Topotecan delivery to the optic nerve after ophthalmic artery chemosurgery","volume":"11","author":"Taich","year":"2016","journal-title":"PLoS One"}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493119307143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493119307143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:42:35Z","timestamp":1760532155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928493119307143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":47,"alternative-id":["S0928493119307143"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2019.109799","relation":{},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrogel implants for transscleral drug delivery for retinoblastoma treatment","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2019.109799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109799"}}